Poplar (Populus spp
Time of Update: 2021-01-18
Thus, it has often been necessary to re-optimize a protocol each time research is initiated with a new genotype.
Detection of siRNAs and miRNAs
Time of Update: 2020-11-18
Understanding these fundamental processes requires the sensitive and specific detection of small RNA species.
Anther Culture of Chili Pepper (Capsicum spp
Time of Update: 2020-11-13
In this chapter, a protocol for efficient recovery of chili pepper haploid plants from in vitro cultured anthers is described.
Micropropagation of Rhododendron
Time of Update: 2020-11-05
Also acclimatization procedures are described.
Protocols for callus, shoot, and root induction are described.
In 2017, U.S. generic drugs cut prices every month. Is this an opportunity or disaster for China
Time of Update: 2017-12-26
Source: e-drug manager approved the largest number of generic drug listing applications in the past five years from December to 26, 2017 by the US FDA
The price dispute
By 2020, the global market for specific drugs will reach US $1.4 trillion
Time of Update: 2015-12-10
In a conference call related to the annual report, Murray Aitken, executive director of the IMS Research Institute, said: the Institute expects a large number of innovative drugs to emerge, and 225 new drugs will enter the market by 2020.
Influence geometry of priority evaluation of new 17 varieties
Time of Update: 2015-09-17
Source: pharmaceutical economic news, September 17, 2015, recently announced on the official website of the national health and Family Planning Commission, in order to speed up
If you want to go far, generic drugs have to go through doctors first
Time of Update: 2015-08-18
Source: Biovalley 2015-08-18, August 18, 2015, in the past two years, the word "patent cliff" has been widely mentioned by people in the biomedical industry
As a result
Preview: academician Chen Kaixian, research and development branch of innovative drugs
Time of Update: 2015-07-24
Chen Kaixian, academician of the third branch of innovative drug research and development of 2015 international bioeconomy conference, made a keynote report on drug innovation
EU recommends approval of the first insulin bio generic
Time of Update: 2014-07-01
Source: DXY on July 1, 2014, the European Drug Administration announced that CHMP had adopted a positive opinion to recommend and approve the listing of nosiphyllis (insulin glargine) biosimilars jointly developed by Lilly and Boehringer Ingelheim.